Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.47756
-0.08624 (-15.30%)
At close: Sep 17, 2026
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $1.57 million as of September 18, 2026. Its market cap has decreased by -43.19% in one year.
Market Cap
1.57M
Enterprise Value
-368.46K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.48
ChartMarket Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 1.57M, a decrease of -94.29%. That is a compound annual growth rate of -26.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 1.57M | -27.33% |
| Dec 31, 2025 | 2.17M | -47.28% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 2.45M |
| Enzolytics | 2.42M |
| Abpro Holdings | 2.30M |
| VitaSpring Biomedical | 2.30M |
| Nymox Pharmaceutical | 2.10M |
| AccuStem Sciences | 2.09M |
| Protagenic Therapeutics | 1.65M |
| AXIM Biotechnologies | 1.38M |